IIT Roorkee开发了一个本土纳米体平台, 加速疾病抗体发现, IIT Roorkee developed a homegrown nanobody platform to accelerate antibody discovery for diseases, boosting India’s healthcare independence.

IIT Roorkee的研究人员利用一个大型、多样的纳米体图书馆,创建了土著抗体发现平台,从而能够更快地识别癌症、感染和自主免疫紊乱等疾病的稳定、高亲近性抗体。 Researchers at IIT Roorkee have created an indigenous antibody discovery platform using a large, diverse nanobody library, enabling faster identification of stable, high-affinity antibodies for diseases like cancer, infections, and autoimmune disorders. 该技术旨在缩短诊断和治疗的发展时间,支持印度的自力更生目标,改善获得负担得起的医疗保健的机会。 The technology aims to shorten development times for diagnostics and treatments, supporting India’s self-reliance goals and improving access to affordable healthcare. IIT Roorkee将与IMGENEX India合作,转让技术,用于扩大规模和现实世界测试,提高国内生物技术能力和大流行病防备。 Partnering with IMGENEX India, IIT Roorkee will transfer the technology for scale-up and real-world testing, advancing domestic biotech capabilities and pandemic preparedness.